Bioadaptives Stock Market Value
| BDPT Stock | USD 0.04 0.01 19.77% |
| Symbol | BioAdaptives |
BioAdaptives 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioAdaptives' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioAdaptives.
| 07/30/2023 |
| 07/19/2025 |
If you would invest 0.00 in BioAdaptives on July 30, 2023 and sell it all today you would earn a total of 0.00 from holding BioAdaptives or generate 0.0% return on investment in BioAdaptives over 720 days. BioAdaptives is related to or competes with Bit Origin. BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals More
BioAdaptives Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioAdaptives' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioAdaptives upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 18.4 | |||
| Information Ratio | 2.0E-4 | |||
| Maximum Drawdown | 74.59 | |||
| Value At Risk | (25.00) | |||
| Potential Upside | 32.85 |
BioAdaptives Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioAdaptives' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioAdaptives' standard deviation. In reality, there are many statistical measures that can use BioAdaptives historical prices to predict the future BioAdaptives' volatility.| Risk Adjusted Performance | 0.0177 | |||
| Jensen Alpha | 0.2182 | |||
| Total Risk Alpha | (2.15) | |||
| Sortino Ratio | 2.0E-4 | |||
| Treynor Ratio | (0.21) |
BioAdaptives Backtested Returns
Currently, BioAdaptives is out of control. BioAdaptives secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for BioAdaptives, which you can use to evaluate the volatility of the firm. Please confirm BioAdaptives' Downside Deviation of 18.4, mean deviation of 10.58, and Risk Adjusted Performance of 0.0177 to double-check if the risk estimate we provide is consistent with the expected return of 0.1%. The firm shows a Beta (market volatility) of -0.64, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning BioAdaptives are expected to decrease at a much lower rate. During the bear market, BioAdaptives is likely to outperform the market. BioAdaptives right now shows a risk of 15.48%. Please confirm BioAdaptives treynor ratio and the relationship between the semi variance and relative strength index , to decide if BioAdaptives will be following its price patterns.
Auto-correlation | 0.31 |
Below average predictability
BioAdaptives has below average predictability. Overlapping area represents the amount of predictability between BioAdaptives time series from 30th of July 2023 to 24th of July 2024 and 24th of July 2024 to 19th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioAdaptives price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current BioAdaptives price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | 0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
BioAdaptives lagged returns against current returns
Autocorrelation, which is BioAdaptives pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioAdaptives' pink sheet expected returns. We can calculate the autocorrelation of BioAdaptives returns to help us make a trade decision. For example, suppose you find that BioAdaptives has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioAdaptives regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioAdaptives pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioAdaptives pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioAdaptives pink sheet over time.
Current vs Lagged Prices |
| Timeline |
BioAdaptives Lagged Returns
When evaluating BioAdaptives' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioAdaptives pink sheet have on its future price. BioAdaptives autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioAdaptives autocorrelation shows the relationship between BioAdaptives pink sheet current value and its past values and can show if there is a momentum factor associated with investing in BioAdaptives.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioAdaptives Pink Sheet Analysis
When running BioAdaptives' price analysis, check to measure BioAdaptives' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAdaptives is operating at the current time. Most of BioAdaptives' value examination focuses on studying past and present price action to predict the probability of BioAdaptives' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAdaptives' price. Additionally, you may evaluate how the addition of BioAdaptives to your portfolios can decrease your overall portfolio volatility.